InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,010.60
(
0.87%
)
US TECH 100
16,796.40
(
0.26%
)
Dow Jones
38,239.98
(
0.67%
)
Brent Oil
86.67
(
0.30%
)
Bitcoin
66,246.77
(
-0.91%
)
Post# of 1140
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

blue_skies

Send PM Follow Ignore
Followers 14
Posts 2848
Boards Moderated 0
Alias Born 12/23/2014

blue_skies

Re: Paullee post# 1077

Tuesday, 01/04/2022 10:35:49 AM

Tuesday, January 04, 2022 10:35:49 AM

Post# of 1140
the DYAI platform is attractive enough to pharma that they will sign structured deals. This is non dilutive funding. I will take it.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent DYAI News
More DYAI News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM

Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Start posting your company's news
Only $200 per official company press release!